Literature DB >> 303703

Predominance of autoimmune and rheumatic diseases in females.

R E Kast.   

Abstract

This paper offers an explanation for the higher female incidence found in many of the autoimmune and rheumatic diseases. A list of these diseases (Table 1) shows that half of them occur in three females for each male affected. Females are genetic and hence antigenic mosaics, half their somatic cells expressing antigens derived from the paternal X, half from the maternal X (female heterochromatinization). The Burnet-Jerne theory of somatic generation of antibody diversity and forbidden clone elimination states that lymphocytes under maturation in the thymus are killed or suppressed if they recognize and hence react to a histocompatibility antigen. If this were to hold for other self antigens as well, as recent models of clonal generation and selection mechanisms predict, then lymphocytes happening to pass the crucial stage in the thymus meeting only cells expressing one of the parental X's could be released still able to react to self i.e. those somatic cells expressing the other parental X with which the lymphocyte had not been in contact. Thus, self-tolerance would be more easily broken in females than in males.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 303703

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  9 in total

1.  Extremely skewed X-chromosome inactivation is increased in pre-eclampsia.

Authors:  Elif Uz; Ismail Dolen; Atakan R Al; Tayfun Ozcelik
Journal:  Hum Genet       Date:  2006-11-07       Impact factor: 4.132

Review 2.  X chromosome inactivation and female predisposition to autoimmunity.

Authors:  Tayfun Ozcelik
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 8.667

Review 3.  The sex bias in systemic sclerosis: on the possible mechanisms underlying the female disease preponderance.

Authors:  Fabio D'Amico; Evangelia Skarmoutsou; Maria Clorinda Mazzarino
Journal:  Clin Rev Allergy Immunol       Date:  2014-12       Impact factor: 8.667

Review 4.  The X chromosome in immune functions: when a chromosome makes the difference.

Authors:  Claude Libert; Lien Dejager; Iris Pinheiro
Journal:  Nat Rev Immunol       Date:  2010-08       Impact factor: 53.106

5.  Skewed X-chromosome inactivation in scleroderma.

Authors:  Elif Uz; Laurence S Loubiere; Vijayakrishna K Gadi; Zeynep Ozbalkan; Jeffrey Stewart; J Lee Nelson; Tayfun Ozcelik
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 8.667

6.  The genetic basis of graves' disease.

Authors:  Rafał Płoski; Konrad Szymański; Tomasz Bednarczuk
Journal:  Curr Genomics       Date:  2011-12       Impact factor: 2.236

7.  Intragenomic Conflict and Immune Tolerance: Do Selfish X-Linked Alleles Drive Skewed X Chromosome Inactivation?

Authors:  Scott W Roy
Journal:  Genome Biol Evol       Date:  2018-03-01       Impact factor: 3.416

Review 8.  X-Chromosome Inactivation and Related Diseases.

Authors:  Zhuo Sun; Jinbo Fan; Yang Wang
Journal:  Genet Res (Camb)       Date:  2022-03-27       Impact factor: 1.588

9.  Analysis of skewed X-chromosome inactivation in females with rheumatoid arthritis and autoimmune thyroid diseases.

Authors:  Ghazi Chabchoub; Elif Uz; Abdellatif Maalej; Chigdem A Mustafa; Ahmed Rebai; Mouna Mnif; Zouheir Bahloul; Nadir R Farid; Tayfun Ozcelik; Hammadi Ayadi
Journal:  Arthritis Res Ther       Date:  2009-07-09       Impact factor: 5.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.